BioRestorative Therapies ...

NASDAQ: BRTX · Real-Time Price · USD
1.51
0.01 (0.65%)
At close: Aug 15, 2025, 3:50 PM
1.52
0.66%
After-hours: Aug 15, 2025, 04:00 PM EDT

BioRestorative Therapies Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
401K 145.8K 119.8K 46K
Cost of Revenue
28.07K 165.74K 120.54K 205.21K
Gross Profit
372.93K -19.93K 119.8K 46K
Operating Income
-11.56M -15.22M -18.97M -26.31M
Interest Income
616.08K 552.29K 11.65K n/a
Pretax Income
-8.98M -10.42M -13.22M -44.3M
Net Income
-8.98M -10.42M -13.22M -44.3M
Selling & General & Admin
6.58M 11.33M 15.58M 25.62M
Research & Development
5.35M 4.03M 3.51M 729.06K
Other Expenses
n/a n/a n/a n/a
Operating Expenses
11.93M 15.37M 19.09M 26.35M
Interest Expense
n/a n/a n/a 1.82M
Selling & Marketing Expenses
n/a 168.03K 163.13K 12.29K
Cost & Expenses
11.96M 15.37M 19.09M 26.35M
Income Tax Expense
n/a n/a -479.26K -14.36M
Shares Outstanding (Basic)
7.76M 4.22M 3.62M 1.19M
Shares Outstanding (Diluted)
7.76M 4.22M 3.62M 1.19M
EPS (Basic)
-1.16 -2.47 -3.65 -37.3
EPS (Diluted)
-1.16 -2.47 -3.65 -37.3
EBITDA
-11.37M -10.25M -18.85M -26.22M
EBIT
-11.56M -10.42M -18.97M -26.31M
Depreciation & Amortization
189.06K 165.74K 120.54K 205.21K